Whole Shine Medical Technology Co., Ltd. (SHE:002622)
China · Delayed Price · Currency is CNY 2.730
-0.010 (-0.36%)
May 15, 2026, 3:04 PM CST
SHE:002622 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -126.05 | -129.93 | -37.69 | -94.37 | -256.79 | -75.98 |
Depreciation & Amortization | 56.14 | 56.14 | 64.32 | 63.66 | 63.35 | 16.06 |
Other Amortization | 16.98 | 16.98 | 14.78 | 13.75 | 10.87 | 1.59 |
Loss (Gain) From Sale of Assets | -0.71 | -0.71 | 0.58 | -4.22 | -0.87 | -0.03 |
Asset Writedown & Restructuring Costs | 54.99 | 54.99 | 0.21 | 0.1 | 21.29 | 14.64 |
Loss (Gain) From Sale of Investments | 1.08 | 1.08 | 3.7 | 73.61 | -76.98 | 17.43 |
Provision & Write-off of Bad Debts | - | - | 3.36 | 2.51 | 2.84 | 0.63 |
Other Operating Activities | 54.49 | 37.89 | 63.12 | 82.52 | 38.46 | 42.87 |
Change in Accounts Receivable | 15.14 | 15.14 | -28.09 | 45.65 | -21.72 | 36.71 |
Change in Inventory | 8.28 | 8.28 | 11.39 | -8.31 | -2.17 | -3.98 |
Change in Accounts Payable | 4.55 | 4.55 | 5.12 | -35.02 | 260.07 | -32.46 |
Change in Other Net Operating Assets | 2.42 | 2.42 | -10.28 | -3.1 | 2.97 | 0.64 |
Operating Cash Flow | 86.49 | 66.01 | 92.36 | 137.02 | 32.25 | 18.37 |
Operating Cash Flow Growth | -0.74% | -28.53% | -32.59% | 324.94% | 75.56% | -71.89% |
Capital Expenditures | -22.02 | -21.9 | -13.79 | -33.63 | -23.99 | -5.74 |
Sale of Property, Plant & Equipment | 0.26 | 0.26 | 0.01 | 0.68 | 0.21 | 0.05 |
Cash Acquisitions | - | - | - | - | -20.69 | -34.37 |
Divestitures | - | - | - | 17.6 | 11.89 | - |
Investment in Securities | - | - | - | - | 74 | 94 |
Other Investing Activities | - | - | 0.71 | 3.39 | - | - |
Investing Cash Flow | -21.77 | -21.64 | -13.06 | -11.95 | 41.42 | 53.94 |
Long-Term Debt Issued | - | - | 78.4 | 17 | 90.5 | - |
Long-Term Debt Repaid | - | -0.5 | -142.01 | -93.02 | -213.23 | -40.58 |
Net Debt Issued (Repaid) | -0.5 | -0.5 | -63.61 | -76.02 | -122.73 | -40.58 |
Issuance of Common Stock | 8.33 | 8.33 | - | - | - | - |
Common Dividends Paid | -14.63 | -15.07 | -25.53 | -25.37 | -22.64 | -34.63 |
Other Financing Activities | -47.04 | -47.2 | -0.5 | - | 1.26 | 0.1 |
Financing Cash Flow | -53.85 | -54.43 | -89.64 | -101.39 | -144.1 | -75.11 |
Foreign Exchange Rate Adjustments | -0 | -0 | 0 | -0 | - | - |
Net Cash Flow | 10.87 | -10.06 | -10.35 | 23.69 | -70.43 | -2.8 |
Free Cash Flow | 64.46 | 44.12 | 78.57 | 103.4 | 8.26 | 12.63 |
Free Cash Flow Growth | -14.03% | -43.85% | -24.01% | 1152.17% | -34.62% | -80.49% |
Free Cash Flow Margin | 9.28% | 6.28% | 9.12% | 13.66% | 1.65% | 7.51% |
Free Cash Flow Per Share | 0.08 | 0.05 | 0.09 | 0.12 | 0.01 | 0.01 |
Cash Income Tax Paid | 7.93 | 8.86 | 8.86 | 2.95 | 9.93 | 5.16 |
Levered Free Cash Flow | 98.96 | 82.75 | 85.66 | 102.25 | 293.55 | 83.58 |
Unlevered Free Cash Flow | 98.96 | 82.75 | 112.46 | 130.14 | 332.67 | 107.84 |
Change in Working Capital | 29.57 | 29.57 | -20.02 | -0.55 | 230.08 | 1.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.